These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 34148210

  • 1. Exploitation of nanocrystal suspension as an effective oral formulation for oxfendazole.
    Sun Y, Chen D, Zhao Y, Zhou K, Zhang B, Wang H, Xie S.
    Drug Deliv Transl Res; 2022 May; 12(5):1219-1229. PubMed ID: 34148210
    [Abstract] [Full Text] [Related]

  • 2. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S, Reddy VA, Arora S, Patel K.
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [Abstract] [Full Text] [Related]

  • 3. Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
    Wang Y, Wang S, Xu Y, Wang P, Li S, Liu L, Liu M, Jin X.
    Int J Nanomedicine; 2020 Oct; 15():7601-7613. PubMed ID: 33116490
    [Abstract] [Full Text] [Related]

  • 4. Fabrication of Ibrutinib Nanosuspension by Quality by Design  Approach: Intended for Enhanced Oral Bioavailability and Diminished Fast Fed Variability.
    Rangaraj N, Pailla SR, Chowta P, Sampathi S.
    AAPS PharmSciTech; 2019 Oct 28; 20(8):326. PubMed ID: 31659558
    [Abstract] [Full Text] [Related]

  • 5. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
    Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S.
    Int J Pharm; 2015 Jan 30; 478(2):540-52. PubMed ID: 25490182
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY, Shah DA, Dave RH.
    Int J Pharm; 2019 Mar 25; 559():348-359. PubMed ID: 30721724
    [Abstract] [Full Text] [Related]

  • 9. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C, Dang Y, Lin G, Yao Y, Li G, Ji G, Shen H, Xie Y.
    Int J Pharm; 2014 Dec 30; 477(1-2):251-60. PubMed ID: 25445518
    [Abstract] [Full Text] [Related]

  • 10. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK, Patel MH, Patel K.
    Drug Dev Ind Pharm; 2016 Dec 30; 42(5):758-68. PubMed ID: 26548349
    [Abstract] [Full Text] [Related]

  • 11. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation.
    Allam AN, Hamdallah SI, Abdallah OY.
    Int J Nanomedicine; 2017 Dec 30; 12():4733-4745. PubMed ID: 28740381
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X, Sun C, Jiang T, Zheng L, Wang T, Wang S.
    J Pharm Pharm Sci; 2011 Dec 30; 14(2):196-214. PubMed ID: 21733409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
    Gera S, Talluri S, Rangaraj N, Sampathi S.
    AAPS PharmSciTech; 2017 Nov 30; 18(8):3151-3162. PubMed ID: 28534300
    [Abstract] [Full Text] [Related]

  • 18. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
    Wang Y, Han X, Wang J, Wang Y.
    Int J Pharm; 2016 May 30; 505(1-2):35-41. PubMed ID: 27034003
    [Abstract] [Full Text] [Related]

  • 19. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
    Jiang T, Han N, Zhao B, Xie Y, Wang S.
    Drug Dev Ind Pharm; 2012 Oct 30; 38(10):1230-9. PubMed ID: 22229827
    [Abstract] [Full Text] [Related]

  • 20. Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals.
    Jain S, Patel K, Arora S, Reddy VA, Dora CP.
    Drug Deliv Transl Res; 2017 Apr 30; 7(2):292-303. PubMed ID: 28116656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.